{
    "clinical_study": {
        "@rank": "45285", 
        "arm_group": [
            {
                "arm_group_label": "N02RS1 200mg", 
                "arm_group_type": "Experimental", 
                "description": "Combination of Broussonetia spp and Lonicera spp"
            }, 
            {
                "arm_group_label": "N02RS1 400mg", 
                "arm_group_type": "Experimental", 
                "description": "Combination of Broussonetia spp and Lonicera spp"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Sugar pill"
            }
        ], 
        "brief_summary": {
            "textblock": "The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the\n      Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With\n      acute and acute exacerbation of chronic bronchitis for 7 days."
        }, 
        "brief_title": "Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Acute Exacerbation of Chronic Bronchitis", 
        "condition_browse": {
            "mesh_term": [
                "Bronchitis", 
                "Acute Disease", 
                "Bronchitis, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18, under 75 years of age\n\n          -  Patients Acute and Chronic Bronchitis\n\n        Exclusion Criteria:\n\n          -  Patients who have gotten a glucocorticoids treatment within 4 weeks.\n\n          -  Patients who need treatments of antibiotic and acute bronchitis infection.\n\n          -  Patients who have gotten teatments of antibiotic,bronchodilator,painkiller and\n             secretagog within 7 days.\n\n          -  Bronchial asthma patient.\n\n          -  Patients who have an indication of bleeding.\n\n          -  Patients who have a serious heart and renal disease or liver ailment or\n             immunosuppressive response.\n\n          -  Patients who have history of over 3 phage of Chronic obstructiv lung disease\n\n          -  Bronchiectasis patients."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979926", 
            "org_study_id": "PMK-N02RS1"
        }, 
        "intervention": {
            "arm_group_label": [
                "N02RS1 200mg", 
                "N02RS1 400mg", 
                "Placebo"
            ], 
            "description": "600 mg/ day or 1200 mg/ day for 7 days", 
            "intervention_name": "Combination of Broussonetia spp and Lonicera spp", 
            "intervention_type": "Drug", 
            "other_name": "N02RS1"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul Nat'l University of Boramae Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis", 
        "overall_official": {
            "affiliation": "Korea Pharmaceutical Manufacturers Association", 
            "last_name": "Wayne B An, Bs", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "1.Adverse Event: symptom, start day and time, end day and time, injection time, severity, progress, outcome, relation with investigational product.", 
            "measure": "Safety", 
            "safety_issue": "No", 
            "time_frame": "12weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979926"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Before and after physical examination\nBefore and after bital Sign: blood pressure, pulse rate, temperature.\nBefore and after Lanza Score at the duodenum and stomach\nLab: hematologic examination, blood coagulation examination,urine examination\nCumulative incidence rate of an endoscopic peptic ulcer.", 
            "measure": "Efficacy", 
            "safety_issue": "No", 
            "time_frame": "12weeks"
        }, 
        "source": "PharmaKing", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PharmaKing", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}